4basebio Investors

en

  • de
Toggle navigation Menu
  • Investment Case
    • Welche Kryptowährung Kaufen
    • Analyst Reports
    • Takeover offer Kromi
    • Sparta offer
    • Spin-off Project
  • Financial Reporting
  • Events
    • Extraordinary General Meeting 2021
    • Extraordinary General Meeting 2020
    • Corporate Calendar
    • Events Calendar
    • Annual General Meeting
    • Extraordinary General Meeting 2019
  • News
    • 2020 Share Buy Back
    • Ad Hoc Releases
    • Press Releases
    • Regulatory News
  • Share Price Information
  • Corporate Governance
    • Corporate Governance Report
    • Declaration of Conformity
    • Code of Ethics
    • Risk Management
    • Management Board
    • Supervisory Board
    • Bylaws Supervisory Board
    • Shareholder Structure
    • Prospectus
    • Articles of Association as PDF (German Language only)
    • Directors Dealings
  • About Us
    • Contact us

Shareholder Structure

Home > Shareholder Structure

The information is based on assumption of 4basebio AG using the last published announcements pursuant to the German Securities Trading Act [WpHG] and the registered voting rights at the last AGM as well as notifications that the Company received.

Current number of shares outstanding: 51,733,386

In this section

  • Annual General Meeting

    View
  • Annual General Meeting 2020

    The Annual General Meeting of 4basebio AG was held on…

    View
  • Annual Report

    View
  • Company Snapshot

    Gene therapy and gene vaccines are mega-trends in personalised medicine…

    View
  • Contact us

    4basebio AG Waldhofer Str. 102 69123 Heidelberg Germany Contact details…

    View
  • Corporate Calendar

    View
  • Corporate Governance

    View
  • Extraordinary General Meeting 2019

    The Extraordinary General Meeting of EXPEDEON AG was held on…

    View
  • Extraordinary General Meeting 2020

    The Extraordinary General Meeting (EGM) of 4basebio AG took place…

    View
  • Extraordinary General Meeting 2021

    The Extraordinary General Meeting (EGM) of 4basebio AG will take…

    View
  • Financial Reporting

    By decision of the Annual General Meeting on 17 October…

    View
  • Imprint

    Combined legal notice (provider identification) under the Telemediengesetz (TMG, Electronic…

    View
  • Investment Case

    View
  • IR Information Service subscription

    View
  • Share Price Information

    See more information on Bloomberg here

    View
View share price information IR Information Service subscription Visit www.4basebio.com for product sales and information
4basebio Investors
  • Home
  • Financial Reporting
  • Events Calendar
  • News Centre
  • Share Price Information
  • Corporate Governance
  • Imprint

© 2021 4basebio. Data Protection.

Website by 23ccc

4basebio AG is the new name of Expedeon AG; its ticker symbol has changed to 4BSB from EXNN.


4basebio AG ist der neue Name der Expedeon AG; Das Tickersymbol wurde von EXNN auf 4BSB geändert.